ARVEE

Arvee Laboratories (India) Share Price

 

 

Start SIP in ARVEE

Start SIP

Performance

  • Low
  • ₹222
  • High
  • ₹230
  • 52 Week Low
  • ₹127
  • 52 Week High
  • ₹291
  • Open Price₹222
  • Previous Close₹234
  • Volume3,839

Investment Returns

  • Over 1 Month + 38.28%
  • Over 3 Month + 36.2%
  • Over 6 Month + 37.74%
  • Over 1 Year + 21.09%

Smart Investing Starts Here Start SIP with Arvee Laboratories (India) for Steady Growth!

Invest Now

Arvee Laboratories (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 625.3
  • PEG Ratio
  • -7.6
  • Market Cap Cr
  • 252
  • P/B Ratio
  • 8
  • Average True Range
  • 20.16
  • EPS
  • 0.37
  • Dividend Yield
  • 0
  • MACD Signal
  • 18.46
  • RSI
  • 56.19
  • MFI
  • 74.31

Arvee Laboratories (India) Financials

Arvee Laboratories (India) Technicals

EMA & SMA

Current Price
₹228.80
-4.82 (-2.06%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹219.32
  • 50 Day
  • ₹194.47
  • 100 Day
  • ₹181.62
  • 200 Day
  • ₹173.84

Resistance and Support

238.08 Pivot Speed
  • R3 255.92
  • R2 251.46
  • R1 242.54
  • S1 229.16
  • S2 224.70
  • S3 215.78

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Arvee Laboratories (India) has an operating revenue of Rs. 26.29 Cr. on a trailing 12-month basis. An annual revenue growth of 26% is outstanding, Pre-tax margin of 7% is okay, ROE of 6% is fair but needs improvement. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 35% and 46% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 8% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 11 which is a POOR score indicating inconsistency in earnings, a RS Rating of 92 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 128 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Arvee Laboratories (India) Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-08-12 Quarterly Results
2025-05-09 Audited Results & Others To consider Other business matters.
2025-02-12 Quarterly Results
2024-11-14 Quarterly Results & Others To consider other business matters.

Arvee Laboratories (India) F&O

Arvee Laboratories (India) Shareholding Pattern

73.5%
26.19%
0.31%

About Arvee Laboratories (India)

  • NSE Symbol
  • ARVEE
  • BSE Symbol
  • Managing Director
  • Mr. Shalin Sudhakarbhai Patel
  • ISIN
  • INE006Z01016

Similar Stocks to Arvee Laboratories (India)

Arvee Laboratories (India) FAQs

Arvee Laboratories (India) share price is ₹228 As on 30 December, 2025 | 11:45

The Market Cap of Arvee Laboratories (India) is ₹252.1 Cr As on 30 December, 2025 | 11:45

The P/E ratio of Arvee Laboratories (India) is 625.3 As on 30 December, 2025 | 11:45

The PB ratio of Arvee Laboratories (India) is 8 As on 30 December, 2025 | 11:45

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23